Using Cross-Dressing to Enhance Anti-Tumor Immune Responses
Invention type: Technology
/
Case number: #21679
Provided herein are compositions and methods of use relating to a novel class of dendritic cells, referred to herein as ISG+ DC, having anti-tumor activity.
Researchers
Stefani Spranger
/
Ellen Duong
Departments: Department of Biology
Technology Areas: Biotechnology: Sensors & Monitoring / Chemicals & Materials: Nanotechnology & Nanomaterials / Diagnostics: Assays / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living
-
compositions and methods for using cross-dressing to enhance anti-tumor immune responses
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.